Ajanta Pharma Ltd share price logo

Ajanta Pharma Share Price

NSE: AJANTPHARM

BSE: 532331

Mid Cap

Healthcare Sector

2791.20

-25.60

(-0.91%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Ajanta Pharma Stock Performance

as on April 2, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,722.80
    ₹2,816.80
    downward going graph

    2.45%

    Downside

    0.92%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹2,327.30
    ₹3,228.00
    downward going graph

    16.62%

    Downside

    15.65%

    Upside

    downward going graph

Ajanta Pharma share price movements today

Previous Close
₹2,816.80
Open
₹2,816.00
Volume
52.99K
Upper Circuit
₹3,380.10
Lower Circuit
₹2,253.50
Day's Low - High
₹2,722.80 - ₹2,816.80
52 Week Low - High
₹2,327.30 - ₹3,228.00

Ajanta Pharma Historical Returns

1 Month Return
-6.17 %
3 Month Return
-4.17 %
1 Year Return
+ 17.55 %
3 Year Return
+ 120.97 %
5 Year Return
+ 140.3 %

Ajanta Pharma Fundamentals

as on April 2, 2026 at 4:01 pm IST

Market Cap

₹34,872.03 Cr

Return on Equity (ROE)

26.05

PE Ratio (TTM)

34.38

Return on capital employed (ROCE)

32.78

Industry PE ratio

40.5

Beta (LTM)

0.66

P/B Ratio

9.05

Dividend Yield

1.07

PEG Ratio

3.56

Quarterly Earnings Growth YOY

17.56

EPS (TTM)

73.43

Sector

Pharmaceuticals

Book Value

302.38

Technical Analysis

Ajanta Pharma Stock Valuation

as on April 2, 2026 at 4:01 pm IST

Ajanta Pharma in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (34.38x)

April 2, 2026

Industry (40.50x)

April 2, 2026

Highest (50.52x)

September 10, 2024

LowHigh

Today’s Price to Earnings Ratio: 34.38x

Ajanta Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY34,872.0328.06%0.529204,648
BUY7,519.30-11.84%0.524132,013
BUY77,461.5110.24%0.603,48331,723
HOLD86,963.7719.29%0.614,61423,241
BUY55,855.6314.68%0.001,4146,445

Market expectation of Ajanta Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

92.86%

Buy

0.00%

Hold

7.14%

Sell

Ajanta Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
1,021.04
1,028.44
1,105.15
1,054.08
1,144.92
1,186.64
1,146.13
1,170.41
1,302.65
1,353.73
1,374.84
Other Income
31.75
21.33
13.59
35.5
26.47
19.48
30.44
18.11
26.33
59.34
24.97
Total Income
1,052.79
1,049.77
1,118.74
1,089.58
1,171.39
1,206.12
1,176.57
1,188.52
1,328.98
1,413.07
1,399.81
Expenses
749.72
737.78
791.08
775.76
814.57
875.47
825.3
873.26
951.3
1,025.9
992.6
Operating Profit
271.32
290.66
314.07
278.32
330.35
311.17
320.83
297.15
351.35
327.83
382.24
Operating Profit Margin %
26.57%
28.26%
28.42%
26.4%
28.85%
26.22%
27.99%
25.39%
26.97%
24.22%
27.8%
Profit Before Interest, Tax and Depreciation
303.07
311.99
327.66
313.82
356.82
330.65
351.27
315.26
377.68
387.17
407.21
Interest
0.85
2.34
2.49
1.53
0.73
6.02
7.91
6.07
5.26
3.39
5.1
Depreciation
33.18
33.71
34.26
34.25
33.97
34.39
35.97
39.78
41.29
42.97
43.51
Profit Before Tax
269.04
275.94
290.91
278.04
322.12
290.24
307.39
269.41
331.13
340.81
358.6
Tax Paid
60.92
80.64
80.88
75.32
76.35
73.76
74.51
44.15
75.79
80.62
84.83
Profit After Tax
208.12
195.3
210.03
202.72
245.77
216.48
232.88
225.26
255.34
260.19
273.77
Total Net profit including share of profit / Loss from associate company
208.12
195.3
210.03
202.72
245.77
216.48
232.88
225.26
255.34
260.19
273.77
EPS
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
20.83
21.91
Actual EPS
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
20.83
21.91
Adjusted EPS
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
20.83
21.91
Diluted EPS
16.53
15.5
16.67
16.09
19.53
17.26
18.59
18
20.43
20.82
21.91

Ajanta Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
2,130.86
2,055.37
2,587.87
2,889.69
3,340.99
3,742.64
4,208.71
4,648.1
Other Income
24.16
21.08
92.19
25.98
115.68
98.64
84.6
94.5
Total Income
2,155.02
2,076.45
2,680.06
2,915.67
3,456.67
3,841.28
4,293.31
4,742.6
Expenses
1,472.47
1,488.94
1,908.46
1,891.13
2,411.69
2,959.39
3,036.77
3,388.6
Operating Profit
658.39
566.43
679.41
998.56
929.3
783.25
1,171.94
1,259.5
Operating Profit Margin %
30.9%
27.56%
26.25%
34.56%
27.82%
20.93%
27.85%
27.1%
Profit Before Interest, Tax and Depreciation
682.55
587.51
771.6
1,024.54
1,044.98
881.89
1,256.54
1,354
Interest
0.41
1.16
11.91
8.27
10.2
5.84
7.21
20.73
Depreciation
59.59
72.08
95.72
116.09
125.3
130.8
135.4
144.11
Profit Before Tax
622.55
514.27
663.97
900.18
909.48
745.25
1,113.93
1,189.16
Tax Paid
153.91
127.3
196.27
246.31
196.8
157.27
297.76
268.77
Profit After Tax
468.64
386.97
467.7
653.87
712.68
587.98
816.17
920.39
Total Net profit including share of profit / Loss from associate company
468.64
386.97
467.7
653.87
712.68
587.98
816.17
920.39
EPS
53.26
43.97
53.6
75.09
54.97
49.89
64.82
73.56
Actual EPS
53.26
43.97
53.6
75.09
54.97
49.89
64.82
73.56
Adjusted EPS
35.51
29.31
35.73
50.06
36.65
49.89
64.82
73.56
Diluted EPS
53.25
43.96
53.6
75.09
54.96
45.89
64.77
73.33

Ajanta Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
326.15
609.29
281.12
374.51
456.77
576.31
561.71
792.11
785.07
1,157.23
Cash Flow from Investing Activities
88.86
-84.01
6.6
120.19
15.02
-110.77
74.74
-385.11
217.8
-58.6
Cash Flow from Financing Activities
-117.32
-201.77
-0.2
-147.46
-128.63
-318.29
-459.71
-108.2
-1,051.06
-733.41
Net Cash Flow
-0.23
24.4
24.81
4.27
103.74
-24.36
27.9
124.31
-200.6
47.3

Ajanta Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
66.21%
66.21%
66.21%
66.21%
66.27%
66.26%
66.26%
66.26%
66.26%
66.25%
66.25%
DII
14.7%
14.91%
16.01%
17.49%
17.41%
17.1%
17.02%
17.48%
17.5%
17.9%
18.58%
FII
0%
0%
0%
8.54%
8.36%
9.11%
9.26%
8.86%
8.86%
8.53%
7.98%
Government
0%
0%
0%
0%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
7.78%
8.2%
8.01%
7.76%
7.94%
7.52%
7.45%
7.39%
7.38%
7.32%
7.19%
Total Outstanding Shares
12,59,15,655
12,59,15,655
12,59,15,655
12,59,15,655
12,48,87,774
12,49,12,099
12,49,12,099
12,49,12,099
12,49,12,099
12,49,35,624
12,49,35,624
Total Shareholders
54,874
56,277
54,351
55,488
70,316
64,315
66,896
70,827
68,882
67,785
65,409

Mutual Funds that own Ajanta Pharma Stock

Check out the Mutual Funds with significant holdings in Ajanta Pharma.

Ajanta Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Ajanta Pharma.

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 17.56% since last year same period to ₹273.77Cr in the Q3 2025-2026. On a quarterly growth basis, Ajanta Pharma Ltd has generated 5.22% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Ajanta Pharma Ltd Dividends November,2025

    In the quarter ending September 2025, Ajanta Pharma Ltd has declared dividend of ₹28.00 per share on 03 Nov 2025 - translating a dividend yield of 1.00%.

    Read More about Dividends

Indices Featuring Ajanta Pharma Stock

Check stock indices that include Ajanta Pharma.

NIFTY PHARMA

₹21,808.40

-0.92 (203.20%)

S&P BSE 400 MidSmallCap

₹10,726.34

-0.15 (15.73%)

BSE Healthcare

₹41,371.63

-0.75 (312.71%)

Nifty Midcap 150

₹19,805.50

-0.32 (63.60%)

Nifty MidSmallcap 400

₹17,927.05

-0.27 (48.40%)

S&P BSE 150 MidCap

₹14,567.37

-0.24 (34.91%)

BSE 500

₹32,839.65

0.08 (24.68%)

Nifty LargeMidcap 250

₹14,851.55

-0.09 (13.85%)

S&P BSE 250 LargeMidCap

₹9,814.98

0.08 (7.68%)

Nifty 500

₹20,938.35

0.02 (3.20%)

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 225.26 Cr → 273.77 Cr (in ₹), with an average increase of 6.2% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.67% to 15.49% in Dec 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.25% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 245.2% return, outperforming this stock by 124.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.3% return, outperforming this stock by 5.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.41K Cr → 1.39K Cr (in ₹), with an average decrease of 0.9% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.32% to 7.19% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AJANTPHARM stock has moved down by -0.5%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.53% to 7.98% in Dec 2025 quarter

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Revenue: ₹1,374.84Cr as on December 2025 (Q3 FY26)
Net Profit: ₹273.77Cr as on December 2025 (Q3 FY26)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
IndustryPharmaceuticals
CEOMannalal B Agrawal
E-voting on sharesClick here to vote

FAQs

What is Ajanta Pharma share price today?

Ajanta Pharma share price today stands at ₹2791.2 as on at the close of the market. Ajanta Pharma share today touched a day high of ₹2816.8 and a low of ₹2722.8.

What is the 52 week high and 52 week low range for Ajanta Pharma share?

Ajanta Pharma touched a 52 week high of ₹3228 and a 52 week low of ₹2327.3. Ajanta Pharma share price today i.e. is closed at ₹2791.2, which is -13.53% down from its 52 week high and 19.93% up from its 52 week low.

What is Ajanta Pharma's market capitalisation today?

Ajanta Pharma market capitalisation is ₹34,872.03 Cr as on .

How to buy Ajanta Pharma shares?

To buy Ajanta Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AJANTPHARM or Ajanta Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ajanta Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ajanta Pharma trading volume today?

Ajanta Pharma trading volume is 52.99K as on . This means that 52.99K shares of Ajanta Pharma were bought and sold on the stock market during today's trading session.